Lentivirus Infections  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lentivirus Infections
NCT00131560: Safety and Efficacy of T Cell Genetic Immunotherapy for HIV

Active, not recruiting
2
60
US
VRX496-Modified Autologous T cells
VIRxSYS Corporation
HIV Infection
11/08
06/23
Rollover, NCT00622232: A Study for Subjects Who Completed Participation in the VRX496-USA-05-002 Trial

Active, not recruiting
2
40
US
VRX496-transduced autologous CD4 T cells
VIRxSYS Corporation
HIV Infections
01/09
06/23
NCT00010348: Study of Total Body Irradiation in Combination With Allogeneic Peripheral Blood Stem Cell or Bone Marrow Transplantation Followed By Cyclosporine and Mycophenolate Mofetil in High Risk-Patients With Human Immunodeficiency Virus-1

Recruiting
2
20
US
Cyclosporine, Mycophenolate mofetil, Total body irradiation and stem cell or bone marrow transplantation
Fred Hutchinson Cancer Research Center
HIV Infections
12/10
12/15

Download Options